Expression of Syk in invasive breast cancer: Correlation to proliferation and invasiveness

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4949-4954

  Repana, Katerina ^a   Papazisis, Konstantinos ^b   Foukas, Periklis ^c,d   Valeri, Rozalia ^b   Kortsaris, Alexandros ^e   Deligiorgi, Eleni ^c   Kyriakidis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d Locus Medicus Laboratory   (Greece)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Breast cancer; Chemokines; Intravascular disease; Metastasis; Syk

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; PROTEIN KINASE SYK;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CELL GROWTH PROCESSES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B;

EID: 33845921924     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Turner M, Schweighoffer E, Colucci F, Di Santo JP and Tybulewicz VL: Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 21: 148-154, 2000.
2. Futterer K, Wong J, Grucza RA, Chan AC and Waksman G: Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol 281: 523-537, 1998.
3. Kurosaki T: Molecular mechanisms in B cell antigen receptor signaling. Curr Opin Immunol 9: 309-318, 1997.
4. Chu DH, Morita CT and Weiss A: The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 165: 167-180, 1998.
5. Kiefer F, Brumell J, Al-Alawi N, Latour S, Cheng A, Veillette A, Grinstein S and Pawson T: The Syk protein tyrosine kinase is essential for Fcγ receptor signalling in macrophages and neutrophils. Mol Cell Biol 18: 4209-4220, 1998.
6. Brumbaugh K, Binstadt BA, Billadeau DD, Schoon RA, Dick CJ, Ten RM and Leibson PJ: Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med 186: 1965-1974, 1997.
7. Yanagi S, Inatome R, Takano T and Yamamura H: Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun 288: 495-498, 2001.
8. Fluck M, Zurche G, Andres AC and Ziemiecki A: Molecular characterisation of the murine Syk protein tyrosine kinase cDNA transcripts and protein. Biochem Biophys Res Commun 231: 273-281, 1995.
9. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH and Mueller SC: The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406: 742-747, 2000.
10. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z and Fuji Y: Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 189: 97-102, 2003.
11. Moroni M, Soldatenkov V, Zhang L, Y. Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M and Mueller S: Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64: 7346-7354, 2004.
12. Wang S, Ding Y, Chen G, Xia J and Wu Z: Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 10: 1815-1818, 2004.
13. Nakashima H, Natsugoe S, Ishigami S, Okumura H, Matsumoto M, Hokita S and Aikou T: Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett 236: 89-94, 2006.
14. Yuan Y, Mendez R, Sahin A and Le Dai J: Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61: 5558-5561, 2001.
15. Yuan Y, Liu H, Sahin A and Le Dai J: Reactivation of Syk expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Int J Cancer 113: 654-659, 2005.
16. Zyss D, Montcourrier P, Vidal B, Anguille C, Merezegue F, Sahuquet A, Mangeat PH and Coopman PJ: The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression. Cancer Res 65: 10872-10880, 2005.
17. Wang L, Devarajan E, He J, Reddy SP and Dai JL: Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Cancer Res 65: 10289-10297, 2005.
18. Baggiolini M, Dewald B and Moser B: Human chemokines, an update. Annu Rev Immunol 15: 675-705, 1997.
19. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and metastasis. Cancer Sci 96: 317-322, 2005.
20. Muller A, Homey B, Soto H, Ge N, Carton D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera J, Mohar A, Verastegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
21. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M and Czarnetzki BM: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151: 2667-2675, 1993.
22. Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K and Watanabe A: Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother 47: 47-57, 1998.
23. Youngs SJ, Ali SA, Taub DD and Rees RC: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71: 257-266, 1997.
24. Sparmann A and Bar-Sagi D: Ras-induced Interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6: 447-458, 2004.
25. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
26. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
27. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
28. Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R and Dai JL: Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 63: 4724-4730, 2003.
29. Khandaker MH, Xu L, Rahimpour R, Mitchell G, DeVries ME, Pickering G, Singhal SK, Feldman RD and Kelvin DJ: CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J Immunol 161: 1930-1938, 1998.
30. Guinamard R, Signoret N, Ishiai M, Marsh M, Kurosaki T and Ravetch JV: B cell receptor engagement inhibits stromal cell-derived factor (SDF)-1a chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J Exp Med 189: 1461-1466, 1999.